Pankreas Duktal Adenokanserinde Evreleme, Raporlama

Ezgi GÜLER, (Ege Üniversitesi)
Nevra ELMAS (Ege Üniversitesi)
Türk Radyoloji Seminerleri
2 1
Yıl: 2019 Cilt: 7 Sayı: 2 Sayfa Aralığı: 172 - 180 Metin Dili: Türkçe DOI: 10.5152/trs.2019.752 İndeks Tarihi: 04-05-2020

Pankreas Duktal Adenokanserinde Evreleme, Raporlama

Öz:
-
Anahtar Kelime:

Konular: Radyoloji, Nükleer Tıp, Tıbbi Görüntüleme
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1]. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30.
  • [2]. Seufferlein T, Bachet JB, VanCutsem E, Rougier P; ESMO Guidelines Working Group. Pancreatic adenocarcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23(suppl 7): vii33-40. [CrossRef]
  • [3]. Valls C, Andía E, Sanchez A, Fabregat J, Pozuelo O, Quintero JC, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 2002; 178: 821-6. [CrossRef]
  • [4]. Ishikawa O, Ohigashi H, Imaoka S, Furukawa H, Sasaki Y, Fujita M, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992; 215: 231-6. [CrossRef]
  • [5]. Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, et al. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg 2014; 18: 269-78. [CrossRef]
  • [6]. Zaky AM, Wolfgang CL, Weiss MJ, Javed AA, Fishman EK, Zaheer A. Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning. Radiographics 2017; 37: 93-112. [CrossRef]
  • [7]. Fletcher JG, Wiersema MJ, Farrell MA, Fidler JL, Burgart LJ, Koyama T, et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 2003; 229: 81-90. [CrossRef]
  • [8]. Treadwell JR, Zafar HM, Mitchell MD, Tipton K, Teitelbaum U, Jue J. Imaging tests for the diagnosis and staging of pancreatic adenocarcinoma: a meta-analysis. Pancreas 2016; 45: 789-95. [CrossRef]
  • [9]. Chen FM, Ni JM, Zhang ZY, Zhang L, Li B, Jiang CJ. Presurgical evaluation of pancreatic cancer: a comprehensive imaging comparison of CT versus MRI. AJR Am J Roentgenol 2016; 206: 526-35. [CrossRef]
  • [10]. Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholan- giopancreatography versus MDCT. J Magn Reson Imaging 2009; 30: 58695. [CrossRef]
  • [11]. Koelblinger C, Ba-Ssalamah A, Goetzinger P, Puchner S, Weber M, Sahora K, et al. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology 2011; 259: 757-66. [CrossRef]
  • [12]. Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, et al. Pancreatic adenocarcinoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2012; 10: 703-13. [CrossRef]
  • [13]. Soloff EV, Zaheer A, Meier J, Zins M, Tamm EP. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease. Abdom Radiol (NY) 2018; 43: 301-13. [CrossRef]
  • [14]. Low G, Panu A, Millo N, Leen E. Multimodality imaging of neoplastic and non-neoplastic solid lesions of the pancreas. Radiographics 2011; 31: 9931015. [CrossRef]
  • [15]. Legrand L, Duchatelle V, Molinié V, Boulay-Coletta I, Sibileau E, Zins M. Pancreatic adenocarcinoma: MRI conspicuity and pathologic correlations. Abdom Imaging 2015; 40: 85-94. [CrossRef]
  • [16]. Ahualli J. The double duct sign. Radiology 2007; 244: 314-5. [CrossRef]
  • [17]. Elmas N, Oran I, Oyar O, Ozer H. A new criterion in differentiation of pancreatitis and pancreatic car cinoma: artery-to-vein ratio using the superior mesenteric vessels. Abdom Imaging 1996; 21: 331-3. [CrossRef]
  • [18]. Hough TJ, Raptopoulos V, Siewert B, Matthews JB. Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol 1999; 173: 1509-12. [CrossRef]
  • [19]. Bowman AW, Bolan CW. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging. Abdom Radiol (NY) 2019; 44: 936-49. [CrossRef]
  • [20]. Mahul B. Amin. AJCC Cancer Staging Manual. 8th ed. Springer, ISBN 978-3-319-40617-6; 2016.
  • [21]. Vauthey JN, Dixon E. AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol 2009; 16: 17256. [CrossRef]
  • [22]. Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, et al. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 2012; 255: 103-8. [CrossRef]
  • [23]. Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 2014; 270: 248-60. [CrossRef]
  • [24]. Hazirolan T, Metin Y, Karaosmanoglu AD, Canyigit M, Turkbey B, Oguz BS, et al. Mesenteric arterial variations detected at MDCT angiography of abdominal aorta. AJR Am J Roentgenol 2009; 192: 1097102. [CrossRef]
  • [25]. Sugae T, Fujii T, Kodera Y, Kanzaki A, Yamamura K, Yamada S, et al. Classification of the celiac axis stenosis owing to median arcuate ligament compression, based on severity of the stenosis with subsequent proposals for management during pancreatoduodenectomy. Surgery 2012; 151: 543-9. [CrossRef]
APA Guler E, Elmas N (2019). Pankreas Duktal Adenokanserinde Evreleme, Raporlama. , 172 - 180. 10.5152/trs.2019.752
Chicago Guler Ezgi,Elmas Nevra Pankreas Duktal Adenokanserinde Evreleme, Raporlama. (2019): 172 - 180. 10.5152/trs.2019.752
MLA Guler Ezgi,Elmas Nevra Pankreas Duktal Adenokanserinde Evreleme, Raporlama. , 2019, ss.172 - 180. 10.5152/trs.2019.752
AMA Guler E,Elmas N Pankreas Duktal Adenokanserinde Evreleme, Raporlama. . 2019; 172 - 180. 10.5152/trs.2019.752
Vancouver Guler E,Elmas N Pankreas Duktal Adenokanserinde Evreleme, Raporlama. . 2019; 172 - 180. 10.5152/trs.2019.752
IEEE Guler E,Elmas N "Pankreas Duktal Adenokanserinde Evreleme, Raporlama." , ss.172 - 180, 2019. 10.5152/trs.2019.752
ISNAD Guler, Ezgi - Elmas, Nevra. "Pankreas Duktal Adenokanserinde Evreleme, Raporlama". (2019), 172-180. https://doi.org/10.5152/trs.2019.752
APA Guler E, Elmas N (2019). Pankreas Duktal Adenokanserinde Evreleme, Raporlama. Türk Radyoloji Seminerleri, 7(2), 172 - 180. 10.5152/trs.2019.752
Chicago Guler Ezgi,Elmas Nevra Pankreas Duktal Adenokanserinde Evreleme, Raporlama. Türk Radyoloji Seminerleri 7, no.2 (2019): 172 - 180. 10.5152/trs.2019.752
MLA Guler Ezgi,Elmas Nevra Pankreas Duktal Adenokanserinde Evreleme, Raporlama. Türk Radyoloji Seminerleri, vol.7, no.2, 2019, ss.172 - 180. 10.5152/trs.2019.752
AMA Guler E,Elmas N Pankreas Duktal Adenokanserinde Evreleme, Raporlama. Türk Radyoloji Seminerleri. 2019; 7(2): 172 - 180. 10.5152/trs.2019.752
Vancouver Guler E,Elmas N Pankreas Duktal Adenokanserinde Evreleme, Raporlama. Türk Radyoloji Seminerleri. 2019; 7(2): 172 - 180. 10.5152/trs.2019.752
IEEE Guler E,Elmas N "Pankreas Duktal Adenokanserinde Evreleme, Raporlama." Türk Radyoloji Seminerleri, 7, ss.172 - 180, 2019. 10.5152/trs.2019.752
ISNAD Guler, Ezgi - Elmas, Nevra. "Pankreas Duktal Adenokanserinde Evreleme, Raporlama". Türk Radyoloji Seminerleri 7/2 (2019), 172-180. https://doi.org/10.5152/trs.2019.752
Sayfa Oluşturulma Tarihi
23-04-2024 11:29

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları